REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/30/2026
Back to search
Official data from USPTO
NEUROGENX INNOVATIVE NEUROGENIC SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
05/31/2026
Trademark type
Combined
Nice classes
10, 44
Filing date
10/19/2016
Registration date
05/30/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/10/2024
Last transaction
05/31/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2012-08-00
First use in commerce
2012-08-00
Drawing code
3
Owner type
03
Owner location
Lansing, MI, US
Examiner
JENKINS, KEISHA MONIQUE HARD
Law office
M30
Current location
TMO LAW OFFICE 112
Mark description
The mark consists of the word "NEUROGENX" in which the "O" is made of a group of intersecting circles. Below the word "NEUROGENX" are the words "INNOVATIVE NEUROGENIC SOLUTIONS".
Holders and representatives
Holders
Neurogenx, Inc.
Representatives
Vincent S. Egolf CORNER COUNSEL, LLC
Technical classification
Nice Classes
Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Electrical stimulation apparatus for treatment for neuropathy symptoms and neuromuscular pain in the feetlegshands and arms
Class 44
Medical servicestreatment for neuropathy symptoms and neuromuscular pain in the feetlegshands and arms
Publications
History of USPTO decisions and trademark events.
23 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/10/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/10/2024
E815
TEAS SECTION 8 & 15 RECEIVED
11/08/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/30/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/08/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/30/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2017
PUBO
PUBLISHED FOR OPPOSITION
03/14/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
01/31/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/31/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
01/31/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/31/2017
DOCK
ASSIGNED TO EXAMINER
01/29/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/26/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/25/2016
NWAP
NEW APPLICATION ENTERED
10/22/2016
Continuous trademark protection
Get notified about every new filing that threatens NEUROGENX INNOVATIVE NEUROGENIC SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.